JP2002363097A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2002363097A5 JP2002363097A5 JP2001312701A JP2001312701A JP2002363097A5 JP 2002363097 A5 JP2002363097 A5 JP 2002363097A5 JP 2001312701 A JP2001312701 A JP 2001312701A JP 2001312701 A JP2001312701 A JP 2001312701A JP 2002363097 A5 JP2002363097 A5 JP 2002363097A5
- Authority
- JP
- Japan
- Prior art keywords
- composition according
- composition
- pharmaceutically acceptable
- stabilizer
- weight
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000203 mixture Substances 0.000 description 10
- 239000003381 stabilizer Substances 0.000 description 5
- 150000001875 compounds Chemical class 0.000 description 3
- 239000008194 pharmaceutical composition Substances 0.000 description 3
- 229920001184 polypeptide Polymers 0.000 description 3
- 102000004196 processed proteins & peptides Human genes 0.000 description 3
- 108090000765 processed proteins & peptides Proteins 0.000 description 3
- 150000003839 salts Chemical class 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- 0 CC(CC(N(C*1=C)C(C)C1O)=O)C(*)CC(N)O Chemical compound CC(CC(N(C*1=C)C(C)C1O)=O)C(*)CC(N)O 0.000 description 2
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 125000004122 cyclic group Chemical group 0.000 description 2
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 2
- 239000008101 lactose Substances 0.000 description 2
- 239000008213 purified water Substances 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 125000002252 acyl group Chemical group 0.000 description 1
- 125000000600 disaccharide group Chemical group 0.000 description 1
- 150000002016 disaccharides Chemical class 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 125000003071 maltose group Chemical group 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 239000000178 monomer Substances 0.000 description 1
- 239000003002 pH adjusting agent Substances 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2001312701A JP4691866B2 (ja) | 1999-07-01 | 2001-10-10 | 安定化された凍結乾燥型医薬組成物 |
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP11-187713 | 1999-07-01 | ||
| JP18771399 | 1999-07-01 | ||
| JP1999187713 | 1999-07-01 | ||
| JP2001312701A JP4691866B2 (ja) | 1999-07-01 | 2001-10-10 | 安定化された凍結乾燥型医薬組成物 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2001507492A Division JP3381722B2 (ja) | 1999-07-01 | 2000-06-29 | 安定化された凍結乾燥型医薬組成物 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2002363097A JP2002363097A (ja) | 2002-12-18 |
| JP2002363097A5 true JP2002363097A5 (cg-RX-API-DMAC7.html) | 2007-06-14 |
| JP4691866B2 JP4691866B2 (ja) | 2011-06-01 |
Family
ID=16210881
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2001507492A Expired - Lifetime JP3381722B2 (ja) | 1999-07-01 | 2000-06-29 | 安定化された凍結乾燥型医薬組成物 |
| JP2001312701A Expired - Lifetime JP4691866B2 (ja) | 1999-07-01 | 2001-10-10 | 安定化された凍結乾燥型医薬組成物 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2001507492A Expired - Lifetime JP3381722B2 (ja) | 1999-07-01 | 2000-06-29 | 安定化された凍結乾燥型医薬組成物 |
Country Status (28)
Families Citing this family (33)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI233805B (en) * | 1999-07-01 | 2005-06-11 | Fujisawa Pharmaceutical Co | Stabilized pharmaceutical composition in lyophilized form as antifungal agent |
| ITMI20021040A1 (it) * | 2002-05-16 | 2003-11-17 | Novuspharma Spa | Composizioni farmaceutiche iniettabili di un derivato antracenedionico ad attivita' antitumorale |
| KR101016595B1 (ko) * | 2002-07-31 | 2011-02-22 | 센주 세이야꾸 가부시키가이샤 | 수성액제 및 광안정화된 수성액제 |
| US8877168B1 (en) | 2002-07-31 | 2014-11-04 | Senju Pharmaceuticals Co., Ltd. | Aqueous liquid preparations and light-stabilized aqueous liquid preparations |
| US20060074014A1 (en) * | 2002-11-18 | 2006-04-06 | Vicuron Pharmaceuticals Inc. | Dalbavancin compositions for treatment of bacterial infections |
| US7119061B2 (en) * | 2002-11-18 | 2006-10-10 | Vicuron Pharmaceuticals, Inc. | Dalbavancin compositions for treatment of bacterial infections |
| PT1565201T (pt) * | 2002-11-18 | 2019-02-05 | Vicuron Pharmaceuticals Llc | Métodos de administração de dalbavancina para o tratamento de infeções bacterianas |
| CN100515422C (zh) * | 2004-03-04 | 2009-07-22 | 卫材R&D管理有限公司 | 含有苄脒衍生物的组合物及苄脒衍生物的稳定化方法 |
| WO2005111033A2 (en) * | 2004-05-19 | 2005-11-24 | Neurosearch A/S | Novel azabicyclic aryl derivatives |
| WO2006053383A1 (en) * | 2004-11-22 | 2006-05-26 | Anadis Ltd | Bioactive compositions |
| KR101307999B1 (ko) | 2004-12-01 | 2013-09-12 | 니폰 조키 세야쿠 가부시키가이샤 | 건조물 및 그 제조방법 |
| KR20080028942A (ko) * | 2005-07-20 | 2008-04-02 | 교와 메덱스 가부시키가이샤 | 생체 시료 중의 펩티드의 안정화 방법 |
| CN1962852B (zh) * | 2006-11-27 | 2011-11-09 | 西北农林科技大学 | 红景天多糖在制备抗冻剂中的新用途及其产品和制备方法 |
| CN102614492B (zh) * | 2011-01-31 | 2013-12-11 | 上海天伟生物制药有限公司 | 一种含有棘白菌素类抗真菌剂米卡芬净的液体药用组合物 |
| CN102614491B (zh) | 2011-01-31 | 2014-04-16 | 上海天伟生物制药有限公司 | 一种含有棘白菌素类抗真菌剂米卡芬净的药用组合物及其制备方法和用途 |
| BR112014029108B1 (pt) * | 2012-05-22 | 2022-02-08 | Paion Uk Limited | Composições que compreendem benzodiazepinas de curta ação, uso de uma mistura de pelo menos um dissacarídeo e pelo menos uma dextrana e método de preparação de uma composição farmacêutica |
| ES3026983T3 (en) | 2013-03-15 | 2025-06-12 | Merck Sharp & Dohme Llc | Ceftolozane antibiotic compositions |
| US9872906B2 (en) | 2013-03-15 | 2018-01-23 | Merck Sharp & Dohme Corp. | Ceftolozane antibiotic compositions |
| US20140274991A1 (en) | 2013-03-15 | 2014-09-18 | Cubist Pharmaceuticals, Inc. | Ceftolozane pharmaceutical compositions |
| CN103330932B (zh) * | 2013-04-26 | 2015-12-23 | 江苏豪森药业股份有限公司 | 一种米卡芬净或其盐的药物组合物 |
| CN103330933B (zh) * | 2013-04-26 | 2015-08-05 | 江苏豪森药业股份有限公司 | 含有米卡芬净或其盐的药物组合物 |
| DK3003298T3 (da) * | 2013-06-05 | 2024-06-17 | Univ British Columbia | Antifibrogene forbindelser, fremgangsmåder og anvendelser deraf |
| AU2014233637A1 (en) | 2013-09-09 | 2015-03-26 | Merck Sharp & Dohme Corp. | Treating infections with ceftolozane/tazobactam in subjects having impaired renal function |
| US8906898B1 (en) | 2013-09-27 | 2014-12-09 | Calixa Therapeutics, Inc. | Solid forms of ceftolozane |
| KR101611349B1 (ko) | 2014-04-14 | 2016-04-12 | 신우철 | 안정성이 개선된 밀크씨슬 엑스의 제형 |
| US20170190742A1 (en) * | 2014-05-29 | 2017-07-06 | Shanghai Techwell Biopharmaceutical Co., Ltd. | Composition of cyclic peptide compound, preparation method for same, and uses thereof |
| WO2016088863A1 (ja) * | 2014-12-05 | 2016-06-09 | Ｍｅｉｊｉ Ｓｅｉｋａファルマ株式会社 | ジアザビシクロオクタン誘導体の結晶及び安定な凍結乾燥製剤の製造法 |
| WO2016107890A1 (en) | 2014-12-31 | 2016-07-07 | Galenicum Health S.L. | Stable pharmaceutical compositions comprising micafungin |
| PL3058958T3 (pl) | 2015-02-23 | 2019-02-28 | Selectchemie Ag | Kompozycja anidulafunginy |
| WO2018112330A1 (en) | 2016-12-16 | 2018-06-21 | Baxter International Inc. | Micafungin compositions |
| WO2019005829A1 (en) * | 2017-06-26 | 2019-01-03 | Wayne State University | METHODS AND COMPOSITIONS RELATING TO CANCER DEPENDENT ON HORMONE RECEPTORS |
| RU2666148C1 (ru) * | 2017-10-05 | 2018-09-06 | Общество с ограниченной ответственностью "Новые Антибиотики" | Способ получения водорастворимой лиофилизированной формы соли бис(2-тио-4,6-диоксо-1,2,3,4,5,6-гексагидропиримидин-5-ил)-(4-нитрофенил)метана |
| EP3485873A1 (en) | 2017-11-17 | 2019-05-22 | Cadila Healthcare Limited | Stable pharmaceutical injectable compositions of micafungin |
Family Cites Families (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH03193735A (ja) | 1989-12-22 | 1991-08-23 | Shionogi & Co Ltd | グリコペプチド系抗生物質の安定化組成物 |
| JPH03240727A (ja) | 1990-02-15 | 1991-10-28 | Toyo Jozo Co Ltd | ニューモシスチス・カリニ肺炎治療剤 |
| IE990233A1 (en) * | 1990-06-18 | 2000-11-15 | Fujisawa Pharmaceutical Co | New Polypeptide Compound and a Process for Preparation thereof |
| JP3193735B2 (ja) | 1991-07-24 | 2001-07-30 | 株式会社リコー | カラー画像形成装置の搬送装置 |
| RU2095081C1 (ru) * | 1991-12-13 | 1997-11-10 | Акционерное общество "Биофа" | Фармацевтическая композиция антивирусного действия |
| JPH0651641A (ja) | 1992-07-30 | 1994-02-25 | Olympus Optical Co Ltd | 湿式現像装置 |
| JPH06172204A (ja) * | 1992-12-09 | 1994-06-21 | Asahi Chem Ind Co Ltd | アクレアシン類含有リポソーム製剤およびその製造法 |
| JP3240727B2 (ja) | 1993-02-25 | 2001-12-25 | ソニー株式会社 | 偏平型陰極線管の画像歪補正装置 |
| US6268338B1 (en) * | 1993-04-30 | 2001-07-31 | Merck & Co., Inc. | Cyclohexapeptidyl amine compounds |
| IL109615A (en) * | 1993-05-17 | 2000-12-06 | Fujisawa Pharmaceutical Co | Cyclic polypeptide derivatives processes for the preparation thereof and pharmaceutical compositions containing the same |
| DE122008000025I2 (de) | 1994-10-07 | 2011-02-17 | Astellas Pharma Inc | Zyklische hexapeptide mit antibiotischer aktivität |
| GB9512854D0 (en) * | 1995-06-23 | 1995-08-23 | Wellcome Found | Novel formulation |
| US6245349B1 (en) * | 1996-02-23 | 2001-06-12 | éLAN CORPORATION PLC | Drug delivery compositions suitable for intravenous injection |
| EP1854877B1 (en) * | 1996-03-08 | 2012-02-08 | Astellas Pharma Inc. | Process for the deacylation of cyclic lipopeptides |
| PE63998A1 (es) * | 1996-04-19 | 1998-10-30 | Merck & Co Inc | Composiciones anti-fungosas |
| JPH09301997A (ja) | 1996-05-17 | 1997-11-25 | Yamanouchi Pharmaceut Co Ltd | 新規環状ペプチド系化合物 |
| FR2755857B1 (fr) * | 1996-11-19 | 1998-12-24 | Rhone Poulenc Rorer Sa | Compositions pharmaceutiques stabilisees, a base de quinupristine et de dalfopristine et leur preparation |
| AUPO371596A0 (en) * | 1996-11-19 | 1996-12-12 | Fujisawa Pharmaceutical Co., Ltd. | New compound |
| AUPO381496A0 (en) * | 1996-11-25 | 1996-12-19 | Fujisawa Pharmaceutical Co., Ltd. | New compound |
| JPH10279498A (ja) * | 1997-04-07 | 1998-10-20 | Nippon Shinyaku Co Ltd | 慢性関節リウマチ治療剤 |
| JP3544847B2 (ja) * | 1998-01-16 | 2004-07-21 | 三菱電機株式会社 | 光学的情報再生方法および装置 |
| KR20010112302A (ko) * | 1999-03-03 | 2001-12-20 | 피터 지. 스트링거 | 제약학적 경구용 ｅｃｂ 조제물 및 조성물의 제조 방법 |
| HK1040062A1 (zh) * | 1999-03-03 | 2002-05-24 | Eli Lilly And Company | 含有成胶束表面活性剂的棘白菌素药物配方 |
| TWI233805B (en) * | 1999-07-01 | 2005-06-11 | Fujisawa Pharmaceutical Co | Stabilized pharmaceutical composition in lyophilized form as antifungal agent |
-
2000
- 2000-06-28 TW TW089112754A patent/TWI233805B/zh not_active IP Right Cessation
- 2000-06-29 TR TR2001/00609T patent/TR200100609T1/xx unknown
- 2000-06-29 KR KR10-2001-7002318A patent/KR100454784B1/ko not_active Expired - Lifetime
- 2000-06-29 PL PL346297A patent/PL200141B1/pl unknown
- 2000-06-29 NZ NZ510290A patent/NZ510290A/en not_active IP Right Cessation
- 2000-06-29 RU RU2001108569/15A patent/RU2251411C2/ru active
- 2000-06-29 PT PT00940916T patent/PT1107777E/pt unknown
- 2000-06-29 CA CA2341568A patent/CA2341568C/en not_active Expired - Lifetime
- 2000-06-29 EP EP00940916A patent/EP1107777B1/en not_active Expired - Lifetime
- 2000-06-29 HK HK02101689.2A patent/HK1040057B/zh not_active IP Right Cessation
- 2000-06-29 CN CNB008012164A patent/CN1179748C/zh not_active Expired - Lifetime
- 2000-06-29 JP JP2001507492A patent/JP3381722B2/ja not_active Expired - Lifetime
- 2000-06-29 OA OA1200100048A patent/OA11601A/en unknown
- 2000-06-29 ES ES00940916T patent/ES2225161T3/es not_active Expired - Lifetime
- 2000-06-29 WO PCT/JP2000/004381 patent/WO2001002002A1/en not_active Ceased
- 2000-06-29 MX MXPA01000601A patent/MXPA01000601A/es active IP Right Grant
- 2000-06-29 CN CNB2004100880760A patent/CN100352495C/zh not_active Expired - Lifetime
- 2000-06-29 ID IDW20010749A patent/ID29468A/id unknown
- 2000-06-29 HU HU0103740A patent/HU229089B1/hu unknown
- 2000-06-29 BR BRPI0006823A patent/BRPI0006823B8/pt unknown
- 2000-06-29 IL IL14145500A patent/IL141455A0/xx active IP Right Grant
- 2000-06-29 AU AU55722/00A patent/AU752265B2/en not_active Expired
- 2000-06-29 CZ CZ20011186A patent/CZ295720B6/cs not_active IP Right Cessation
- 2000-06-29 DE DE60015279T patent/DE60015279T2/de not_active Expired - Lifetime
- 2000-06-29 AT AT00940916T patent/ATE280583T1/de active
- 2000-06-29 BR BR0006823-3A patent/BR0006823A/pt not_active IP Right Cessation
- 2000-06-29 US US09/786,125 patent/US6774104B1/en not_active Expired - Lifetime
- 2000-06-30 AR ARP000103372A patent/AR024634A1/es not_active Application Discontinuation
-
2001
- 2001-02-15 IL IL141455A patent/IL141455A/en not_active IP Right Cessation
- 2001-02-22 NO NO20010893A patent/NO330353B1/no not_active IP Right Cessation
- 2001-02-26 ZA ZA200101589A patent/ZA200101589B/en unknown
- 2001-10-10 JP JP2001312701A patent/JP4691866B2/ja not_active Expired - Lifetime
-
2004
- 2004-02-06 US US10/772,281 patent/US7112565B2/en not_active Expired - Lifetime
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2002363097A5 (cg-RX-API-DMAC7.html) | ||
| RU2001108569A (ru) | Стабилизированная фармацевтическая композиция в лиофилизированной форме | |
| JP3623962B2 (ja) | ヒドロキソコバラミンの鼻中投与用医薬組成物 | |
| CA2341568A1 (en) | Stabilized pharmaceutical composition in lyophilized form | |
| CA2288143A1 (en) | Activated protein c formulations | |
| JP2003506416A5 (cg-RX-API-DMAC7.html) | ||
| JP2006516648A5 (cg-RX-API-DMAC7.html) | ||
| JP2004509061A5 (cg-RX-API-DMAC7.html) | ||
| JP2004504406A5 (cg-RX-API-DMAC7.html) | ||
| JPWO2019107530A1 (ja) | 炎症性腸疾患の治療薬 | |
| JP2003532640A5 (cg-RX-API-DMAC7.html) | ||
| KR100546450B1 (ko) | 약학 조성물 | |
| RU2002100058A (ru) | Кристаллические производные 1-метилкарбапенема | |
| KR20220081311A (ko) | 니클로사마이드를 포함하는 근육내 및/또는 피하 투여용 약학적 조성물 | |
| JP2002509154A5 (cg-RX-API-DMAC7.html) | ||
| JP4752987B2 (ja) | 外用剤組成物 | |
| JP2001261578A (ja) | 眼科用組成物 | |
| JP2002080490A (ja) | 新規ヌクレオシド | |
| US5925625A (en) | Pharmaceutical composition for the intranasal administration of hydroxocobalamin | |
| JP2001322936A (ja) | 眼科用組成物 | |
| US10308937B2 (en) | Combination long acting compositions and methods for Hepatitis C | |
| US20170333460A1 (en) | Long acting pharmaceutical compositions for hepatitis c | |
| JP5514270B2 (ja) | アシタザノラスト含有組成物 | |
| JPH0678241B2 (ja) | ｔＰＡ医薬組成物 | |
| JP2007106754A (ja) | アシタザノラスト含有組成物 |